Online inquiry

IVTScrip™ pSP6-VEE-mRNA-Anti-ERBB2&TNFRSF9, PRS-343 Vector   (CAT#: GTVCR-WQ2254MR)

This product GTVCR-WQ2254MR is an effective transcription system suitable for a variety of research, including the in vitro translation, self-amplifying mRNA studies and protein expression. The system was driven by the SP6 promoter to efficiently generate mRNA ecoding antibody which targeting ERBB2&TNFRSF9. The vector contains the self-replicating Venezuelan equine encephalitis (VEE) virus RNA replicon, which resulting the mRNA expression at a high level.

SPECIFIC INQUIRY

3' poly(A):
Inquiry
Specifications
Product type Vector
Promoter SP6
Resistance Ampicillin
Species Chimeric
RefSeq NM_001005862.3; NM_001561.6
Applications IVT; Self-amplifying mRNA (SAM) research; Gene therapy research
Format Solution
Concentration 1 µg/µl
Quantity 10 µg
Target Gene
Gene ID 2064; 3604
UniProt ID P04626; Q07011
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ pSP6-VEE-mRNA-Anti-ERBB2&TNFRSF9, PRS-343 Vector (GTVCR-WQ2254MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTVCR-WQ1512MR IVTScrip™ pT7-VEE-mRNA-Anti-MST1R, IMC RON-8 Vector Vector IMC RON-8
GTVCR-WQ63MR IVTScrip™ pT7-VEE-mRNA-Anti-CD27, 1F5 Vector Vector 1F5
GTVCR-WQ1109MR IVTScrip™ pSP6-VEE-mRNA-Anti-DPEP3, DC-1728001 Vector Vector DC-1728001
GTVCR-WQ700MR IVTScrip™ pT7-VEE-mRNA-Anti-PDCD1, BI-754091 Vector Vector BI-754091
GTVCR-WQ301MR IVTScrip™ pSP6-VEE-mRNA-Anti-IL2RA, ADCT-301 Vector Vector ADCT-301
GTVCR-WQ1127MR IVTScrip™ pT7-VEE-mRNA-Anti-EGFR, DS 1024 Vector Vector DS 1024
GTVCR-WQ288MR IVTScrip™ pT7-VEE-mRNA-Anti-IL1B, ACZ885 Vector Vector ACZ885
GTVCR-WQ1921MR IVTScrip™ pSP6-VEE-mRNA-Anti-ERBB3, MEHD7945A Vector Vector MEHD7945A
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.